FinanceCity
DiversifiedNSE · BSE

SURAKSHA DIAGNOSTIC LIMITED

SURAKSHA · ISIN INE877V01027

Share price

₹274 +2.18%

Market capitalisation

₹1428 CrClosed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹1428 Cr

Current price

₹274

+2.18% today

52W high

₹353

52W low

₹224

Stock P/E

44.42

P/B ratio

6.18

02 · Per share & returns

EPS (TTM)

₹6.17

Book value

₹44.35

ROE

13.84%

ROA

8.70%

Dividend yield

0.19%

Beta

03 · Financials (TTM)

By the numbers

Revenue

₹310 Cr

+31.20% YoY

EBITDA

₹95.86 Cr

Net profit

₹32.19 Cr

-5.40% YoY

Profit margin

10.37%

Operating margin

16.47%

Total debt

₹130 Cr

Total cash

₹26.35 Cr

Debt / equity

0.54x

Current ratio

1.05x

Payout ratio

0.00%

04 · Analyst view

Target price

₹285

Upside

+3.98%

Consensus

NONE

Analysts

1

05 · Shareholding pattern

Who owns SURAKSHA?

Shareholding pattern not yet captured for this company. Pulled from NSE corporate filings on the next ownership refresh.

06 · Registration & listing

On the record

Symbol
SURAKSHA
Exchange
NSE · BSE
CIN
ISIN
INE877V01027
BSE code
544293
Sector
Diversified
Industry
Face value
₹2
Listing date
05 Dec 2024
Employees
Headquarters
Kolkata, India

07 · About

What is SURAKSHA DIAGNOSTIC LIMITED?

Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company also provides Cardiology testing services comprises electrocardiogram, echocardiogram, stress test / treadmill test, wireless holter monitoring, colour doppler, peripheral doppler, and pulmonary function test; gastroenterology, such as upper and lower GI endoscopy, sigmoidoscopy, proctoscopy, colonoscopy, and proctosigmoidoscopy; and neurology testing services, including electroencephalogram, electromyography, and nerve conduction velocity test. In addition, the company provides dental, physiotherapy, immunology & rheumatology, eye, fetal care, ENT, and speciality clinics, as well as home doctor visit services. The company was founded in 1992 and is based in Kolkata, India.

08 · Common questions

Frequently asked

What is the CIN of SURAKSHA DIAGNOSTIC LIMITED?+

The Corporate Identity Number for SURAKSHA DIAGNOSTIC LIMITED is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of SURAKSHA DIAGNOSTIC LIMITED?+

Promoter and group-holding details for SURAKSHA DIAGNOSTIC LIMITED are disclosed quarterly via stock-exchange filings. Detailed pattern is refreshed weekly here from BSE and NSE corporate filings.

What is the market capitalisation of SURAKSHA DIAGNOSTIC LIMITED?+

SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) has a market capitalisation of approximately ₹1428 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent

Other diversified listings

Full sector →